Parkwalk Advisors

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

PhoreMost Limited is a drug discovery company based in Cambridge, United Kingdom, focused on identifying new druggable targets for cancer and other unmet diseases. Since its incorporation in 2014, the company has developed Site-Seeker, a platform that uncovers cryptic druggable sites within the human genome and connects them to therapeutic functions in live-cell contexts. This innovative approach allows PhoreMost to design small molecule drugs based on functionally validated protein fragments. By collaborating with a global network of academic and industrial partners, the company aims to bring novel targeted therapies to market more efficiently, ultimately benefiting patients through cost savings and the development of first-in-class drug discovery programs for potential licensing to pharmaceutical companies.

Nu Quantum Ltd is a company focused on developing quantum photonics hardware and infrastructure essential for scaling quantum computers. Founded in 2018 and based in Cambridge, United Kingdom, the company specializes in creating solutions that interconnect quantum computing cores into large distributed clusters. Its offerings include photon sources and detectors, as well as systems for quantum cryptography that enable secure key exchanges. Nu Quantum is also engaged in producing nano-engineered materials that facilitate light generation at the quantum level and ultra-sensitive light detection. By partnering with leading quantum computing companies, governments, and research institutions, Nu Quantum aims to advance the development of entangled qubit networks and accelerate the creation of multi-core quantum supercomputers and quantum data centers.

Phasecraft is a UK-based company founded in 2018 that develops quantum software aimed at enhancing the practical application of quantum computing. The firm focuses on creating algorithms for quantum information processors, including intermediate-scale devices and quantum computers. By leveraging its expertise in quantum science and engineering, Phasecraft addresses significant industrial challenges, such as optimizing key processes and exploring new materials. The company's software supports clients in investigating innovative quantum materials and developing advanced technologies, including batteries and efficient solar cells. Through its work, Phasecraft aims to facilitate breakthrough scientific discoveries and enable entrepreneurs to tackle pressing global issues more effectively.

RoboK is a computer vision startup based in Cambridge, United Kingdom, founded in 2017. The company specializes in designing and developing simultaneous localization and mapping (SLAM) algorithms and advanced 3D sensing technologies tailored for automotive and industrial applications, including autonomous driving and machine automation. RoboK focuses on enhancing safety and performance in industrial workplaces through innovative, privacy-preserving technology that optimizes the capabilities of existing CCTV systems. By transforming visual data from large-scale transport and logistics infrastructures into actionable insights, RoboK collaborates with major operators in critical sectors to deliver enhanced object detection, classification, and tracking. The company aims to maximize the value of visual data, turning passive surveillance systems into proactive tools for efficiency and safety.

DefiniGEN Limited specializes in providing human cell products for the life science and drug discovery sectors, focusing on applications in predictive toxicology, metabolic diseases, and regenerative medicine. The company’s product offerings include wild-type human hepatocytes and pancreatic cells for research in diabetes, alongside disease-modelled cells for conditions such as glycogen storage disease and hypercholesterolemia. DefiniGEN leverages its advanced stem cell production platform, developed at the University of Cambridge, to create high-functionality cell types that enhance drug discovery processes. The company also offers a range of services, including custom cell production, gene-editing, and diabetes compound profiling, catering primarily to pharmaceutical companies. Established in 2011 and based in Cambridge, UK, DefiniGEN builds on its strong intellectual property foundation, including expertise in induced pluripotent stem cell technology.

Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.

AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

Mind Foundry Limited, headquartered in Oxford, United Kingdom, was founded in 2015 and specializes in developing software that helps organizations extract valuable insights from their data. As a spin-off from Oxford University, Mind Foundry combines innovation with usability through its Responsible AI platform, which addresses significant real-world challenges across various sectors, including insurance, infrastructure, and defense. The company’s technologies apply machine learning and advanced algorithmic modeling to enhance decision-making and problem-solving capabilities for clients. Founded by noted AI and machine learning experts, Mind Foundry aims to foster collaboration between humans and AI, promoting responsible and transparent AI usage while tackling pressing issues such as insurance fraud detection and complex signal processing.

Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.

Qkine Ltd, founded in 2016 and based in Cambridge, United Kingdom, specializes in manufacturing high-purity, animal-free growth factors, cytokines, and complex proteins. The company leverages proprietary protein production processes developed at the University of Cambridge, along with advanced protein engineering techniques, to create unique products that address key challenges in the stem cell, organoid, regenerative medicine, and cultivated meat sectors. Qkine's product line includes innovative offerings such as tag-free thermostable FGF-2, the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF. With an active research and development pipeline and a commitment to quality, Qkine is ISO 9001:2015 certified, ensuring that it provides high-purity, bioactive proteins to support scientific advancements in life sciences.

Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

Concr is a techbio company focused on enhancing cancer treatment by predicting patient responses to various therapies. Utilizing methods from astrophysics, Concr's innovative approach allows for iterative learning from diverse data sources throughout a drug's clinical journey, resulting in accurate multi-modal tumor models without relying on extensive data sets. Its cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses and biomarkers, and conduct standard bioinformatics analyses. This technology aims to identify optimal treatments for individual patients, reduce treatment resistance, and facilitate personalized cancer management. Headquartered in London with a subsidiary in Brisbane, Australia, Concr is backed by several investors, including the University of Cambridge Enterprise and Oncology Ventures.

Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices that utilize patented chip technology to replicate Central Pattern Generators (CPGs) within the human body. Founded in 2016 and based in Bath, United Kingdom, the company’s innovative devices aim to manage various autonomic and rhythmic bodily processes, including peristalsis, heart rate, and walking. Ceryx Medical focuses on restoring normal function in these processes when they are disrupted due to disease or injury, offering potential therapeutic solutions for conditions such as heart failure.

GripAble Ltd. designs and develops digital therapy devices aimed at improving rehabilitation for individuals with movement impairments such as stroke, arthritis, cerebral palsy, and trauma. Founded in 2017 and based in London, the company offers a portable, wireless handgrip device that connects to a mobile application. This application allows users to engage with therapy games while providing assessment and training for hand and arm functions. GripAble's innovative approach focuses on making therapy more accessible and engaging for patients, enabling them to practice essential daily tasks in a fun and motivating way. By combining hardware and software, GripAble addresses the needs of over 500 million people worldwide who face challenges with arm mobility, facilitating self-training both in clinical settings and at home.

Sano Genetics Limited is a health technology company based in Cambridge, United Kingdom, that operates a user-centric genetic data-sharing platform. Founded in 2017, the company enables individuals to contribute their genetic and health data for research purposes, thereby advancing personalized medicine and scientific understanding. It provides researchers with tools to analyze user-consented data, facilitating recruitment for studies and clinical trials. The platform supports research on a variety of genetic conditions and human traits, including common disorders such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. By allowing participants to share their genetic information, Sano Genetics aims to enhance the development of new treatments and cures in the field of medicine.

BibliU Ltd is a software company headquartered in London, UK, with an additional office in New York, that specializes in providing a digital platform for accessing textbooks and educational resources. Founded in 2014, BibliU enables students to access textbooks and other course materials online through various devices, allowing for flexible study options. The company's platform offers features such as offline support, a discovery search tool, and tools for synchronized highlights and comments, enhancing the learning experience and productivity. BibliU collaborates with numerous publishers and open educational resource providers to offer a vast array of digital content, making academic materials more accessible and affordable for colleges and universities.

Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, focused on developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, which is a significant contributor to osteoarthritis, affecting over 300 million individuals worldwide. The company's flagship product, FibroFix, is a hydrogel biomaterial designed to mimic human knee cartilage, offering solutions for repairing both meniscal and articular cartilage. FibroFix Meniscus and FibroFix Cartilage are specifically tailored to restore function and integrate seamlessly with the body's tissues, promoting rapid recovery and improved mobility. Orthox is preparing to enter clinical trials for its lead product and plans to expand the application of its technology to other joints, as well as explore advancements beyond orthopaedics. With the global biomaterials market projected to exceed $250 billion by 2025, Orthox is well-positioned to capitalize on the growing demand for innovative and effective solutions in joint health.

Sano Genetics Limited is a health technology company based in Cambridge, United Kingdom, that operates a user-centric genetic data-sharing platform. Founded in 2017, the company enables individuals to contribute their genetic and health data for research purposes, thereby advancing personalized medicine and scientific understanding. It provides researchers with tools to analyze user-consented data, facilitating recruitment for studies and clinical trials. The platform supports research on a variety of genetic conditions and human traits, including common disorders such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. By allowing participants to share their genetic information, Sano Genetics aims to enhance the development of new treatments and cures in the field of medicine.

Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.

Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

PetMedix Ltd is a veterinary biopharmaceutical company based in Cambridge, United Kingdom, focused on developing therapeutic antibody drugs for pets. Founded in 2017, the company utilizes advanced scientific methods to create innovative therapies that enhance the health and well-being of companion animals. PetMedix offers specialized platforms, including the Ky9 and Felyne transgenic mouse systems, which are designed to produce high-quality, therapeutic antibodies tailored specifically for pets. By leveraging over thirty years of expertise in drug development, PetMedix aims to provide effective medical solutions that meet the unique needs of animals, ensuring they receive appropriate care and treatment.

Nyobolt is a developer of advanced battery technology focused on automotive applications. Founded in 2020 and based in Cambridge, United Kingdom, the company specializes in creating batteries that offer high power, rapid charging capabilities, and substantial energy storage. By utilizing innovative materials, efficient cell designs, and sophisticated software control, Nyobolt aims to provide the automotive industry with solutions tailored for high-power usage. Its research and development efforts are directed toward enhancing battery performance to meet the growing demands of electric vehicles and other automotive technologies.

Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, founded in 2017, that specializes in the development and manufacturing of advanced materials for lithium-ion batteries. The company focuses on producing optimized anode materials, notably its proprietary XNO® material, which enhances charging speed, extends battery lifespan, and improves safety compared to conventional options. Echion aims to serve the mobile device and automotive industries, particularly targeting the heavy-duty electric vehicle market. By offering cost-effective battery electrode materials, Echion strives to promote sustainable electrification and improve efficiency within the transportation sector.

Bonnet Ltd. is a London-based company founded in 2019 that specializes in a charging-as-a-service platform for electric vehicle drivers. The company addresses the challenges faced by drivers who must register separately for multiple public charging networks by offering a single app that enables access to any public charger. This streamlined service caters to both individual drivers and businesses, simplifying the charging process and enhancing the overall user experience for electric vehicle owners.

GripAble Ltd. designs and develops digital therapy devices aimed at improving rehabilitation for individuals with movement impairments such as stroke, arthritis, cerebral palsy, and trauma. Founded in 2017 and based in London, the company offers a portable, wireless handgrip device that connects to a mobile application. This application allows users to engage with therapy games while providing assessment and training for hand and arm functions. GripAble's innovative approach focuses on making therapy more accessible and engaging for patients, enabling them to practice essential daily tasks in a fun and motivating way. By combining hardware and software, GripAble addresses the needs of over 500 million people worldwide who face challenges with arm mobility, facilitating self-training both in clinical settings and at home.

PhoreMost Limited is a drug discovery company based in Cambridge, United Kingdom, focused on identifying new druggable targets for cancer and other unmet diseases. Since its incorporation in 2014, the company has developed Site-Seeker, a platform that uncovers cryptic druggable sites within the human genome and connects them to therapeutic functions in live-cell contexts. This innovative approach allows PhoreMost to design small molecule drugs based on functionally validated protein fragments. By collaborating with a global network of academic and industrial partners, the company aims to bring novel targeted therapies to market more efficiently, ultimately benefiting patients through cost savings and the development of first-in-class drug discovery programs for potential licensing to pharmaceutical companies.

Phasecraft is a UK-based company founded in 2018 that develops quantum software aimed at enhancing the practical application of quantum computing. The firm focuses on creating algorithms for quantum information processors, including intermediate-scale devices and quantum computers. By leveraging its expertise in quantum science and engineering, Phasecraft addresses significant industrial challenges, such as optimizing key processes and exploring new materials. The company's software supports clients in investigating innovative quantum materials and developing advanced technologies, including batteries and efficient solar cells. Through its work, Phasecraft aims to facilitate breakthrough scientific discoveries and enable entrepreneurs to tackle pressing global issues more effectively.

1715 Labs Ltd specializes in data labeling services powered by artificial intelligence. Founded in 2018 and located in Oxford, United Kingdom, the company offers a range of solutions in computer vision and language processing. Its computer vision capabilities include image categorization and various forms of segmentation, while its language processing services encompass text classification, relationship identification, and sentiment recognition, among others. By combining human expertise with advanced statistical tools, 1715 Labs aims to provide organizations with rapid and cost-effective data training, labeling, and analysis, ultimately assisting businesses in effectively utilizing their data. Additionally, 1715 Labs is focused on commercializing Zooniverse technology to expand its offerings in the data labeling market.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

Nyobolt is a developer of advanced battery technology focused on automotive applications. Founded in 2020 and based in Cambridge, United Kingdom, the company specializes in creating batteries that offer high power, rapid charging capabilities, and substantial energy storage. By utilizing innovative materials, efficient cell designs, and sophisticated software control, Nyobolt aims to provide the automotive industry with solutions tailored for high-power usage. Its research and development efforts are directed toward enhancing battery performance to meet the growing demands of electric vehicles and other automotive technologies.

Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices that utilize patented chip technology to replicate Central Pattern Generators (CPGs) within the human body. Founded in 2016 and based in Bath, United Kingdom, the company’s innovative devices aim to manage various autonomic and rhythmic bodily processes, including peristalsis, heart rate, and walking. Ceryx Medical focuses on restoring normal function in these processes when they are disrupted due to disease or injury, offering potential therapeutic solutions for conditions such as heart failure.

Nu Quantum Ltd is a company focused on developing quantum photonics hardware and infrastructure essential for scaling quantum computers. Founded in 2018 and based in Cambridge, United Kingdom, the company specializes in creating solutions that interconnect quantum computing cores into large distributed clusters. Its offerings include photon sources and detectors, as well as systems for quantum cryptography that enable secure key exchanges. Nu Quantum is also engaged in producing nano-engineered materials that facilitate light generation at the quantum level and ultra-sensitive light detection. By partnering with leading quantum computing companies, governments, and research institutions, Nu Quantum aims to advance the development of entangled qubit networks and accelerate the creation of multi-core quantum supercomputers and quantum data centers.

GaitQ Limited, founded in 2019 and based in Oxfordshire, United Kingdom, specializes in developing a medical device aimed at assisting individuals with Parkinson's disease in overcoming freezing of gait. The company's product, known as the GaitThaw device, is small and portable, designed to utilize clinically proven sensory cues. These cues facilitate the re-establishment of the connection between the brain and the body, enabling patients to walk more smoothly and confidently.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices that utilize patented chip technology to replicate Central Pattern Generators (CPGs) within the human body. Founded in 2016 and based in Bath, United Kingdom, the company’s innovative devices aim to manage various autonomic and rhythmic bodily processes, including peristalsis, heart rate, and walking. Ceryx Medical focuses on restoring normal function in these processes when they are disrupted due to disease or injury, offering potential therapeutic solutions for conditions such as heart failure.

Mind Foundry Limited, headquartered in Oxford, United Kingdom, was founded in 2015 and specializes in developing software that helps organizations extract valuable insights from their data. As a spin-off from Oxford University, Mind Foundry combines innovation with usability through its Responsible AI platform, which addresses significant real-world challenges across various sectors, including insurance, infrastructure, and defense. The company’s technologies apply machine learning and advanced algorithmic modeling to enhance decision-making and problem-solving capabilities for clients. Founded by noted AI and machine learning experts, Mind Foundry aims to foster collaboration between humans and AI, promoting responsible and transparent AI usage while tackling pressing issues such as insurance fraud detection and complex signal processing.

Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.

Qkine Ltd, founded in 2016 and based in Cambridge, United Kingdom, specializes in manufacturing high-purity, animal-free growth factors, cytokines, and complex proteins. The company leverages proprietary protein production processes developed at the University of Cambridge, along with advanced protein engineering techniques, to create unique products that address key challenges in the stem cell, organoid, regenerative medicine, and cultivated meat sectors. Qkine's product line includes innovative offerings such as tag-free thermostable FGF-2, the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF. With an active research and development pipeline and a commitment to quality, Qkine is ISO 9001:2015 certified, ensuring that it provides high-purity, bioactive proteins to support scientific advancements in life sciences.

Oxford Flow Ltd. is a company that designs, manufactures, and supplies pressure control equipment, including gas regulators, water pressure reducing valves (PRVs), silencers, and pilots. Established in 2015 and based in Oxford, United Kingdom, the company serves a variety of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow's products are engineered to simplify systems and enhance reliability while meeting rigorous standards for water quality and leakage control. The company focuses on delivering practical solutions that improve operational efficiency and reduce environmental impact, backed by extensive testing and customer feedback. By combining academic expertise with industry knowledge, Oxford Flow aims to provide innovative and efficient pressure control solutions that help customers save costs without compromising performance.

Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development and manufacturing of flow sensor solutions. The company focuses on semiconductor technology, providing mass flow and air velocity sensors tailored for diverse industrial applications. Flusso's innovative sensor products are designed to meet proprietary technology needs across various sectors.

Sorex Sensors Limited specializes in the design and manufacture of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for various industrial and consumer applications. Founded in 2017 and headquartered in the United Kingdom, the company fabricates its devices on silicon wafers, utilizing a thin film of piezoelectric material that resonates to detect mass changes accurately. These sensors are capable of measuring mass down to the femtogram range and can simultaneously monitor temperature with a resolution of 0.2 °C. Their small size and low power consumption make them suitable for diverse applications, including thin film metrology, particulate monitoring, and gas detection. Additionally, the surface of the sensors can be functionalized to selectively detect specific targets, enhancing their versatility in detecting harmful compounds in various environments, such as homes and workplaces.

Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.

RoboK is a computer vision startup based in Cambridge, United Kingdom, founded in 2017. The company specializes in designing and developing simultaneous localization and mapping (SLAM) algorithms and advanced 3D sensing technologies tailored for automotive and industrial applications, including autonomous driving and machine automation. RoboK focuses on enhancing safety and performance in industrial workplaces through innovative, privacy-preserving technology that optimizes the capabilities of existing CCTV systems. By transforming visual data from large-scale transport and logistics infrastructures into actionable insights, RoboK collaborates with major operators in critical sectors to deliver enhanced object detection, classification, and tracking. The company aims to maximize the value of visual data, turning passive surveillance systems into proactive tools for efficiency and safety.

Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.

LettUs Grow is a company based in Bristol, United Kingdom, that specializes in aeroponic irrigation and control technology aimed at enhancing the efficiency and sustainability of indoor farming. Founded in 2015, the company develops modular aeroponic systems that allow plants to grow without soil, using a fine mist for watering and LED lighting to facilitate photosynthesis. Their technology is designed to be nozzle-free and easy to clean, promoting automation and minimizing the need for pesticides. Additionally, LettUs Grow offers farm management software and data services that optimize agricultural practices, helping to reduce labor costs and improve growing conditions for various plant species. By focusing on innovation in farming, LettUs Grow aims to lower the environmental impact of agriculture and support sustainable business practices in the industry.

Covatic Ltd, established in 2016 and headquartered in Birmingham, United Kingdom, specializes in broadcast personalization software. The company's innovative platform employs mobile-based algorithms to enhance user experience by delivering personalized content without compromising personal data. By identifying optimal engagement moments and methods for individuals, Covatic enables clients to effectively connect with their target audiences. This approach allows for the collection and personalization of insights, ultimately improving the way applications serve their users. With an emphasis on problem-solving, Covatic continues to develop solutions that enhance app functionality and user interaction.

Undo Ltd. specializes in developing advanced debugging tools aimed at enhancing software development processes for professionals such as developers, software architects, and product managers. The company offers innovative solutions like LiveRecorder, which records and replays software execution, allowing users to identify and resolve programming errors effectively. Additionally, UndoDB serves as an interactive reversible debugger for C/C++ applications on Linux and Android platforms. By employing time travel debugging technology, Undo enables developers to gain insights into complex code, facilitating the diagnosis of new regressions, legacy bugs, and flaky tests prior to customer impact. The company primarily caters to industries including data management, networking, electronic design automation, and finance. Founded in 2005, Undo Ltd. operates from its headquarters in Cambridge, United Kingdom, and maintains an additional office in San Francisco, California.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. The company's flagship product, PredictSURE IBD, is a diagnostic tool that evaluates patients with inflammatory bowel disease, including Crohn's disease and ulcerative colitis. This test utilizes a small blood sample to identify patients at diagnosis who are at risk of severe, relapsing disease, thereby enabling healthcare providers to recommend early biologic therapy to those who would benefit most. By providing crucial prognostic information, PredictImmune aims to enhance treatment decision-making for physicians and improve outcomes for patients suffering from these conditions. The company's research is rooted in leading studies from Cambridge University, reflecting its commitment to advancing personalized medicine in the field of inflammatory bowel disease.

Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.

Symetrica Ltd. specializes in the development and commercialization of integrated radiation detection and identification technologies tailored for government and custom organizations across the globe. Founded in 2002 and headquartered in Southampton, United Kingdom, with an additional office in Maynard, Massachusetts, the company offers advanced systems that enhance security operations in various sectors, including military and homeland security. Its product range features handheld and backpack-mounted sensors, vehicle-based detectors, and drive-through scanners, all utilizing machine learning to improve threat identification and response. Symetrica's technology is also applicable in fields such as medical diagnostics, geophysical research, and space exploration.

Qkine Ltd, founded in 2016 and based in Cambridge, United Kingdom, specializes in manufacturing high-purity, animal-free growth factors, cytokines, and complex proteins. The company leverages proprietary protein production processes developed at the University of Cambridge, along with advanced protein engineering techniques, to create unique products that address key challenges in the stem cell, organoid, regenerative medicine, and cultivated meat sectors. Qkine's product line includes innovative offerings such as tag-free thermostable FGF-2, the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF. With an active research and development pipeline and a commitment to quality, Qkine is ISO 9001:2015 certified, ensuring that it provides high-purity, bioactive proteins to support scientific advancements in life sciences.

Inductosense Ltd specializes in the manufacture of wireless, battery-free sensors that detect cracks, corrosion, and defects in various structures and products. Founded in 2015 and based in Bristol, United Kingdom, the company has developed the Wireless And Non Destructive (WAND) Evaluation System, which includes a handheld measurement probe and a set of sensors that can be permanently attached to surfaces. These sensors operate under coatings, insulation, or repairs, allowing for efficient and non-invasive inspections. Additionally, Inductosense offers TRND systems designed for monitoring internal corrosion and erosion in pipework and vessels. Their technology facilitates fast, repeatable inspections and enables clients to gather consistent data on structural integrity over time, making it valuable for applications in large structures and composite repairs.

PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.

Cytora is a London-based company founded in 2014 that specializes in a configurable platform designed for commercial insurers to enhance their risk processing capabilities. The platform digitizes incoming risks and enriches them with both internal and external data sources. It evaluates these risks using various rules related to appetite and priority before directing them to downstream systems for either automated or manual underwriting. By leveraging artificial intelligence, Cytora's platform learns the patterns of different risks and loss outcomes over time, allowing insurers to assign a rank, score, and price to each property and organization. This approach aims to improve risk selection, pricing accuracy, and overall efficiency in underwriting processes.

Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Phasecraft is a UK-based company founded in 2018 that develops quantum software aimed at enhancing the practical application of quantum computing. The firm focuses on creating algorithms for quantum information processors, including intermediate-scale devices and quantum computers. By leveraging its expertise in quantum science and engineering, Phasecraft addresses significant industrial challenges, such as optimizing key processes and exploring new materials. The company's software supports clients in investigating innovative quantum materials and developing advanced technologies, including batteries and efficient solar cells. Through its work, Phasecraft aims to facilitate breakthrough scientific discoveries and enable entrepreneurs to tackle pressing global issues more effectively.

Mind Foundry Limited, headquartered in Oxford, United Kingdom, was founded in 2015 and specializes in developing software that helps organizations extract valuable insights from their data. As a spin-off from Oxford University, Mind Foundry combines innovation with usability through its Responsible AI platform, which addresses significant real-world challenges across various sectors, including insurance, infrastructure, and defense. The company’s technologies apply machine learning and advanced algorithmic modeling to enhance decision-making and problem-solving capabilities for clients. Founded by noted AI and machine learning experts, Mind Foundry aims to foster collaboration between humans and AI, promoting responsible and transparent AI usage while tackling pressing issues such as insurance fraud detection and complex signal processing.

Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development and manufacturing of flow sensor solutions. The company focuses on semiconductor technology, providing mass flow and air velocity sensors tailored for diverse industrial applications. Flusso's innovative sensor products are designed to meet proprietary technology needs across various sectors.

Echion Technologies Ltd. is a company based in Cambridge, United Kingdom, founded in 2017, that specializes in the development and manufacturing of advanced materials for lithium-ion batteries. The company focuses on producing optimized anode materials, notably its proprietary XNO® material, which enhances charging speed, extends battery lifespan, and improves safety compared to conventional options. Echion aims to serve the mobile device and automotive industries, particularly targeting the heavy-duty electric vehicle market. By offering cost-effective battery electrode materials, Echion strives to promote sustainable electrification and improve efficiency within the transportation sector.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Undo Ltd. specializes in developing advanced debugging tools aimed at enhancing software development processes for professionals such as developers, software architects, and product managers. The company offers innovative solutions like LiveRecorder, which records and replays software execution, allowing users to identify and resolve programming errors effectively. Additionally, UndoDB serves as an interactive reversible debugger for C/C++ applications on Linux and Android platforms. By employing time travel debugging technology, Undo enables developers to gain insights into complex code, facilitating the diagnosis of new regressions, legacy bugs, and flaky tests prior to customer impact. The company primarily caters to industries including data management, networking, electronic design automation, and finance. Founded in 2005, Undo Ltd. operates from its headquarters in Cambridge, United Kingdom, and maintains an additional office in San Francisco, California.

PhoreMost Limited is a drug discovery company based in Cambridge, United Kingdom, focused on identifying new druggable targets for cancer and other unmet diseases. Since its incorporation in 2014, the company has developed Site-Seeker, a platform that uncovers cryptic druggable sites within the human genome and connects them to therapeutic functions in live-cell contexts. This innovative approach allows PhoreMost to design small molecule drugs based on functionally validated protein fragments. By collaborating with a global network of academic and industrial partners, the company aims to bring novel targeted therapies to market more efficiently, ultimately benefiting patients through cost savings and the development of first-in-class drug discovery programs for potential licensing to pharmaceutical companies.

Salunda Limited specializes in developing robust, contactless sensor technology tailored for monitoring machinery in harsh environments. The company provides a range of innovative solutions, including inline water cut and multiphase flow metering to accurately detect oil, water, and gas fractions from wells. Salunda's sensors are designed to monitor the condition of critical components, such as pistons and rotors, by detecting wear, failure, and movement irregularities. Their technology allows for precise measurement of fluid levels and composition, even in challenging conditions with bubbles and froth present. Additionally, Salunda offers ultra-high temperature speed and position sensors for automotive, aerospace, and industrial applications, ensuring reliable performance under extreme conditions. Established in 2004 and based in Weston on the Green, United Kingdom, Salunda is committed to providing advanced monitoring solutions that enhance operational safety and efficiency in the oil industry and beyond.

Paragraf Ltd. is a UK-based company specializing in the development of graphene technology and the production of two-dimensional materials. Established in 2015, Paragraf focuses on creating graphene-based electronic devices, including magnetic sensors and biosensors, that are designed to enhance technological performance in various sectors such as electronics, energy, research, automation, and healthcare. The company employs contamination-free technology to ensure the production of high-purity graphene products that meet commercial quality standards. Paragraf's innovations aim to optimize process control, improve quality assurance, and facilitate monitoring of environmental and health conditions, thereby contributing to advancements in green energy generation and other critical applications.

Oxford Flow Ltd. is a company that designs, manufactures, and supplies pressure control equipment, including gas regulators, water pressure reducing valves (PRVs), silencers, and pilots. Established in 2015 and based in Oxford, United Kingdom, the company serves a variety of industries such as water, gas, marine, oil and gas, process, power, and building services. Oxford Flow's products are engineered to simplify systems and enhance reliability while meeting rigorous standards for water quality and leakage control. The company focuses on delivering practical solutions that improve operational efficiency and reduce environmental impact, backed by extensive testing and customer feedback. By combining academic expertise with industry knowledge, Oxford Flow aims to provide innovative and efficient pressure control solutions that help customers save costs without compromising performance.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Bodle Technologies Limited specializes in advanced optoelectronic solutions, focusing on innovative display technologies and smart window applications. The company has developed the world's first solid-state reflective display technology, SRD®, which utilizes phase-change materials to deliver vivid colors and video capabilities while consuming no energy for static image storage. This technology addresses common issues such as poor readability in outdoor environments and high power consumption associated with traditional display methods. Bodle Technologies also offers zero-power reflective displays, bi-stable reflective displays with ultra-high resolution, smart windows, and security coatings that can change color through various probing techniques. These products provide enhanced security features for currencies, ID cards, and official documentation. Founded in 2015, Bodle Technologies is headquartered in Begbroke, United Kingdom.

Cytora is a London-based company founded in 2014 that specializes in a configurable platform designed for commercial insurers to enhance their risk processing capabilities. The platform digitizes incoming risks and enriches them with both internal and external data sources. It evaluates these risks using various rules related to appetite and priority before directing them to downstream systems for either automated or manual underwriting. By leveraging artificial intelligence, Cytora's platform learns the patterns of different risks and loss outcomes over time, allowing insurers to assign a rank, score, and price to each property and organization. This approach aims to improve risk selection, pricing accuracy, and overall efficiency in underwriting processes.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

Intelligent Ultrasound is a company that specializes in developing software and training simulators for medical ultrasound applications. Its product offerings include a range of AI-based software solutions like ScanNav Audit, which supports ultrasound practitioners during fetal anomaly scans, and ScanNav AutoCapture, which automatically captures images during ultrasound procedures. The company also provides simulation training platforms such as ScanTrainer, a haptic simulator for obstetrics and gynecology, and HeartWorks, a manikin-based simulator for cardiac and anesthesiology training. These products aim to enhance the quality, reliability, and diagnostic capabilities of ultrasound imaging, ultimately reducing the risk of misdiagnoses. Founded in 2004 and headquartered in Cardiff, the United Kingdom, Intelligent Ultrasound operates in key markets including the UK, North America, and internationally. The company was previously known as MedaPhor Group plc until its rebranding in 2019.

Mind Foundry Limited, headquartered in Oxford, United Kingdom, was founded in 2015 and specializes in developing software that helps organizations extract valuable insights from their data. As a spin-off from Oxford University, Mind Foundry combines innovation with usability through its Responsible AI platform, which addresses significant real-world challenges across various sectors, including insurance, infrastructure, and defense. The company’s technologies apply machine learning and advanced algorithmic modeling to enhance decision-making and problem-solving capabilities for clients. Founded by noted AI and machine learning experts, Mind Foundry aims to foster collaboration between humans and AI, promoting responsible and transparent AI usage while tackling pressing issues such as insurance fraud detection and complex signal processing.

Zegami Limited is a company that specializes in visual data exploration tools designed for the analysis of large collections of images, particularly in scientific and medical contexts. Founded in 2015 and headquartered in Oxford, United Kingdom, Zegami transforms visual data into actionable information by integrating media, data, and artificial intelligence. Its platform supports users in searching, sorting, filtering, and grouping data, which facilitates the identification of patterns, correlations, and anomalies. The solution caters to a variety of sectors, including heating, ventilation, and air conditioning (HVAC) management, microscopy, genomics, and cultural heritage organizations such as galleries and museums. Additionally, Zegami offers a plugin API that enables developers to create custom visualizations, enhancing the platform's versatility and applicability across different fields.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative diagnostic technologies for acute medical settings. Founded in 2014, the company aims to enhance patient care by providing a portable, battery-powered device that enables the detection of heart-related issues, specifically acute coronary syndromes and ischemia. This technology allows for magnetocardiography to be performed directly at the patient's bedside, facilitating timely diagnosis and treatment. Creavo Medical Technologies, which has facilities in Leeds and Coventry, was established by a group of experts in clinical research and business to commercialize advancements developed by Professor Ben Varcoe from Leeds University.

PredictImmune Ltd is a biotechnology company based in Cambridge, United Kingdom, focused on developing prognostic tests for immune-mediated inflammatory diseases. The company's flagship product, PredictSURE IBD, is a diagnostic tool that evaluates patients with inflammatory bowel disease, including Crohn's disease and ulcerative colitis. This test utilizes a small blood sample to identify patients at diagnosis who are at risk of severe, relapsing disease, thereby enabling healthcare providers to recommend early biologic therapy to those who would benefit most. By providing crucial prognostic information, PredictImmune aims to enhance treatment decision-making for physicians and improve outcomes for patients suffering from these conditions. The company's research is rooted in leading studies from Cambridge University, reflecting its commitment to advancing personalized medicine in the field of inflammatory bowel disease.

Azul Optics Limited is a medical device company based in Bristol, United Kingdom, founded in 2016. The company specializes in developing a device that rapidly assesses macular pigment density, an important indicator of eye health. This innovative device is designed to be affordable, fast, easy to use, and compact, facilitating the integration of macular pigment density screening into routine eye examinations. By informing patients about their levels of natural protection, the device empowers individuals with low defenses to take proactive measures for their eye health. Ultimately, Azul Optics aims to support eye health professionals in focusing on the prevention of age-related macular degeneration.

NuNano is a UK-based company specialising in the design and manufacture of probes for atomic force microscopy and cantilever-based sensor devices. It was founded in 2011 by Dr James Vicary and Professors Heinrich Hoerber and Mervyn Miles to bring new manufacturing methods and exemplary levels of customer service to an industry broadly unchanged in 20 years. Building on over 60 years of combined experience in atomic force microscopy, their proprietary microfabrication processes enable us to manufacture AFM probes with the tightest dimensional tolerances in the market at present. They are passionate about providing AFM users with the best possible customer service, from the first time you visit their website to storing your probes after a successful day on the microscope.

BibliU Ltd is a software company headquartered in London, UK, with an additional office in New York, that specializes in providing a digital platform for accessing textbooks and educational resources. Founded in 2014, BibliU enables students to access textbooks and other course materials online through various devices, allowing for flexible study options. The company's platform offers features such as offline support, a discovery search tool, and tools for synchronized highlights and comments, enhancing the learning experience and productivity. BibliU collaborates with numerous publishers and open educational resource providers to offer a vast array of digital content, making academic materials more accessible and affordable for colleges and universities.

Cytora is a London-based company founded in 2014 that specializes in a configurable platform designed for commercial insurers to enhance their risk processing capabilities. The platform digitizes incoming risks and enriches them with both internal and external data sources. It evaluates these risks using various rules related to appetite and priority before directing them to downstream systems for either automated or manual underwriting. By leveraging artificial intelligence, Cytora's platform learns the patterns of different risks and loss outcomes over time, allowing insurers to assign a rank, score, and price to each property and organization. This approach aims to improve risk selection, pricing accuracy, and overall efficiency in underwriting processes.

Polypharmakos Limited, founded in 2016 and based in Witney, United Kingdom, focuses on discovering and developing new antimicrobials derived from plants, fungi, and other natural sources. The company's mission is to tackle the growing global crisis of antimicrobial resistance (AMR) by providing innovative, chemical-free drug treatments. Its products serve various sectors, including pharmaceuticals, consumer health, and agri-tech, aiming to address the urgent need for effective antimicrobial solutions in an era of increasing resistance to conventional treatments.

Exonate is a privately held, early stage, biotech company spun out of the University of Nottingham that is focused on alternative splicing of Vascular Endothelial Growth Factor (VEGF) in ophthalmology. Exonate’s lead programme is focused on Diabetic Macular Oedema (DMO). A consequence of diabetic retinopathy, DMO, is swelling in an area of the retina called the macula and wet Age-Related Macular Degeneration (wAMD), which is the leading cause of vision loss in people aged 60 and older. The Company is founded on scientific excellence with strong links to Professor David Bates and his lab at Nottingham University specializing in the biology and biochemical pathways of VEGF splice variants. Exonate have developed small molecules that inhibit production of pro-angiogenic VEGF through selective inhibition of serine/threonine-protein kinase 1 (SRPK1)-mediated VEGF splicing. These inhibitors have already demonstrated superior efficacy as topical agents in preclinical models of wet AMD. Through a Wellcome Trust funded project, Exonate has completed an optimization programme and has nominated a pre-clinical candidate drug with optimal characteristics. During the second quarter of 2020 regulatory toxicology and safety pharmacology studies have taken place. This is to support the successful application to the regulatory authorities for clinical evaluation. Exonate is led by an experienced, international management team that has previously worked together with cross-disciplinary experience in medicine and drug development, as well as successful fundraising for early stage companies. About Diabetic Macular Oedema (DMO)*: DMO is the build-up of fluid (Oedema) in a region of the retina called the macula. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. DMO is the most common cause of vision loss among people with diabetic retinopathy. About half of all people with diabetic retinopathy will develop DMO and although it is more likely to occur as diabetic retinopathy worsens, DMO can happen at any stage of the disease. About wet Age-Related Macular Degeneration (wet AMD): Today, wet AMD is a leading cause of vision loss in people aged 60 years or older and affects more than 30 million patients worldwide, over 200,000 of those in the UK alone. If untreated patients are likely to lose sight in the affected eye within 24 months of disease onset. The main currently available treatment options for DMO and wet AMD are: • anti-VEGF antibody drugs – to prevent the growth of new blood vessels in the eye. Unlike small molecule drugs or eye drops these treatments must be injected into the eye once every 1 or 2 months. Resistance can develop to these drugs causing the disease to progress anew. • Laser surgery – to destroy abnormal blood vessels in the eye. This type of surgery is only suitable if blood vessel damage is not too extensive and if the abnormal blood vessels aren't close to the fovea, as performing surgery close to this part of the eye can cause permanent vision loss. • With DMO, Corticosteroids either injected or implanted into the eye, may be used alone or in combination with other drugs or laser surgery to treat DMO. *source: https://nei.nih.gov/health/diabetic/retinopathy

Oxford PV is a company based in Oxford, United Kingdom, that specializes in the development and commercialization of thin-film perovskite solar cells. Founded in 2010 by Henry Snaith and Kevin Arthur, the company focuses on integrating these solar cells with traditional silicon solar cells, CIGS solar cells, or glass. Oxford PV's innovative technology enhances photovoltaic performance by effectively capturing specific parts of the solar spectrum, providing a low-cost, thin-film alternative for renewable energy generation. The company's mission supports the global transition to sustainable energy solutions.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Ceres Power Holdings is a UK-based company focused on the development and commercialization of fuel cell technology. Established in 2001 and headquartered in Horsham, the company offers the SteelCell, a technology that converts fuel directly into electrical power using a perforated sheet of steel with specialized ceramic layers. This innovative solution is designed to operate on natural gas and is adaptable for future fuels such as biogas and hydrogen, making it applicable across various sectors including automotive, commercial, data centers, and residential markets. Ceres Power aims to provide cleaner and cost-effective energy solutions, leveraging existing infrastructure and standard manufacturing processes to facilitate widespread adoption. The company has formed strategic collaborations to enhance customer adoption and advance the development of solid oxide fuel cell technology for diverse applications.

Micrima Limited is a company based in Bristol, United Kingdom, specializing in the development and commercialization of advanced imaging technology for early breast cancer detection. The firm has created an ergonomic imaging system branded as MARIA, which employs microwave radar technology to provide non-ionizing imaging services. This system features a horizontal couch and a hemispherical scanning head designed to accommodate various breast sizes without the need for breast compression, offering a more comfortable experience for patients. Micrima is also focused on developing algorithms for processing the data collected during imaging. Initially spun out from research at the University of Bristol, the company has conducted extensive laboratory validation of its technology and is currently conducting human use trials. Micrima primarily serves breast cancer imaging centers and healthcare providers across the UK, aiming to provide a painless and efficient alternative for routine breast cancer screening.

Microsaic Systems is a technology company based in the United Kingdom that specializes in the research, development, and commercialization of miniaturized mass spectrometry instruments. Utilizing micro-electro-mechanical systems technology, the company offers a range of chip-based mass spectrometry solutions, including the 4500 MiD platform for pharmaceutical applications, the MiDas Automated Sampling interface for direct analysis, and the MiD Protein ID spectrometer. Their products cater to various applications such as LCMS, reaction monitoring, and process analytical technology. Additionally, Microsaic provides support services, training programs, and collaborates with original equipment manufacturers and distributors for product sales. The company is evolving its offerings to include AI and Internet of Things analytical sensors, aiming to expand its market reach into sectors like environmental monitoring, aviation, food, and oil and gas. Founded in 1998 and headquartered in Woking, Microsaic Systems continues to innovate in the field of mass spectrometry.

Healthera operates a comprehensive healthcare marketplace in the UK, connecting patients with medicines, healthcare services, and products through a vast digital platform that includes both national pharmacy chains and independent providers. The company's technology facilitates quicker medicine delivery and personalized medical care tailored to individual needs. By reinventing the pharmacy operating model, Healthera enhances patient communication, encourages cross-sales, and fosters customer loyalty. The company is dedicated to digitizing and automating primary care processes, which improves prescribing efficiency and the overall patient experience while minimizing waste for the NHS. Partnering with over 1,000 pharmacies and clinical commissioning groups, Healthera reaches more than 20 million individuals. Its technology is accredited by NHS Digital, positioning Healthera as one of the fastest-growing digital health firms in Europe. Headquartered in Cambridge, the company boasts a diverse international team committed to improving healthcare delivery through human-centered technology.

Salunda Limited specializes in developing robust, contactless sensor technology tailored for monitoring machinery in harsh environments. The company provides a range of innovative solutions, including inline water cut and multiphase flow metering to accurately detect oil, water, and gas fractions from wells. Salunda's sensors are designed to monitor the condition of critical components, such as pistons and rotors, by detecting wear, failure, and movement irregularities. Their technology allows for precise measurement of fluid levels and composition, even in challenging conditions with bubbles and froth present. Additionally, Salunda offers ultra-high temperature speed and position sensors for automotive, aerospace, and industrial applications, ensuring reliable performance under extreme conditions. Established in 2004 and based in Weston on the Green, United Kingdom, Salunda is committed to providing advanced monitoring solutions that enhance operational safety and efficiency in the oil industry and beyond.

DefiniGEN Limited specializes in providing human cell products for the life science and drug discovery sectors, focusing on applications in predictive toxicology, metabolic diseases, and regenerative medicine. The company’s product offerings include wild-type human hepatocytes and pancreatic cells for research in diabetes, alongside disease-modelled cells for conditions such as glycogen storage disease and hypercholesterolemia. DefiniGEN leverages its advanced stem cell production platform, developed at the University of Cambridge, to create high-functionality cell types that enhance drug discovery processes. The company also offers a range of services, including custom cell production, gene-editing, and diabetes compound profiling, catering primarily to pharmaceutical companies. Established in 2011 and based in Cambridge, UK, DefiniGEN builds on its strong intellectual property foundation, including expertise in induced pluripotent stem cell technology.

ROADMap Systems Limited, based in Cambridge, United Kingdom, specializes in advanced technology solutions for fiber optic communication networks. Founded in 2013, the company focuses on wavelength selective switch (WSS) technology, which is essential for creating reconfigurable optical add/drop multiplexers (ROADMs). By leveraging four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics, ROADMap addresses critical challenges faced by network operators, including the need to enhance capacity to meet growing internet data demands, manage operational and capital expenditure pressures, and adapt to rapidly changing service requirements. Their innovative solutions enable highly flexible optical switching that can operate at the wavelength level, accommodating next-generation data rates that conventional switch architectures are unable to support.

Mind Foundry Limited, headquartered in Oxford, United Kingdom, was founded in 2015 and specializes in developing software that helps organizations extract valuable insights from their data. As a spin-off from Oxford University, Mind Foundry combines innovation with usability through its Responsible AI platform, which addresses significant real-world challenges across various sectors, including insurance, infrastructure, and defense. The company’s technologies apply machine learning and advanced algorithmic modeling to enhance decision-making and problem-solving capabilities for clients. Founded by noted AI and machine learning experts, Mind Foundry aims to foster collaboration between humans and AI, promoting responsible and transparent AI usage while tackling pressing issues such as insurance fraud detection and complex signal processing.

Tangentix, a UK-based Sheffield, UK-based startup that is exploring the use of 3D graphics compression.

Navetas Energy Management Ltd. is an energy management company based in Woodbridge, United Kingdom, established in 2008. It specializes in cloud-based energy monitoring and smart data analytics for connected homes, offering solutions that include the Loop platform for monitoring electricity and gas consumption. The Loop platform provides real-time analytics and automated tariff advice, enabling users to track their energy usage and explore various energy tariffs daily through a secure web interface. Additionally, the company provides the Navetas Zeo Smart Hub, which serves as a communications gateway for various metering services, and the Navetas Zeo Smart Gas Meter that utilizes precision fibre optics for gas meter communication. Navetas markets its services directly to consumers on a subscription basis and through online retailers, aiming to enhance energy measurement, procurement, and conservation across residential and commercial sectors.